Brand
Sugarfit
AI Visibility Intelligence
Brand
Sugarfit
Industry
Weight Loss Program
Last updated
2026-05-12
Live AI Knowledge Base
Based on this analysis, we created pages that help Sugarfit show up when buyers search for these questions. These pages are already live at sugarfitglp-com.aikb.tryreadable.ai.
These pages directly address missing visibility
48
out of 100
Losing ~48% of buyers using AI search
Companies with higher scores are more likely to appear in AI-driven purchases.
Losing ~48% of buyers using AI search
Sugarfit is missing in 50% of tracked prompts right now. Every missed answer is a likely lost sale.
Where AI already picks you
This sample does not show a strong attribute lead yet.
Where competitors beat you
What to fix first
Close the Doctor Supervision Required gap before competitors keep owning the recommendation.
Buyers keep seeing competitors on Doctor Supervision Required. Strengthen the proof and page coverage around it before this gap compounds.
Practo is moderate here while Sugarfit is limited.
Need help fixing this?
We'll show where AI is missing Sugarfit, which buyer queries matter most, and what to publish first to improve visibility.
Sugarfit appears in 0% of buyer queries and 100% of direct comparison queries that explicitly mention Sugarfit. Apollo Telehealth appears in 33% of buyer queries.
Comparison Mentions counts only direct comparison prompts that explicitly include Sugarfit. Total Mentions counts all sampled buyer and comparison prompts.
These rows show the competitor brands AI actually surfaces in sampled buyer queries or direct comparison prompts, plus how those same brands carry into overall visibility.
| Brand | Buyer Query Visibility | Comparison Query Visibility | Overall Visibility |
|---|---|---|---|
| Sugarfit Your brand | 0% | 100% | 50% |
| Apollo Telehealth | 33% | 67% | 50% |
| Practo | 33% | 50% | 42% |
Same underlying gaps, reframed around where competitors still capture buyer demand before Sugarfit gets recommended.
Buyer
best GLP-1 weight loss treatment in India
Competitor leading: Apollo Telehealth
Create a buyer-intent page aligned to this query so Sugarfit appears in discovery results.
Buyer
online GLP-1 therapy consultation India
Competitor leading: Apollo Telehealth
Create a buyer-intent page aligned to this query so Sugarfit appears in discovery results.
Buyer
licensed weight loss clinic offering GLP-1 injections near me
Competitor leading: Practo
Create a buyer-intent page aligned to this query so Sugarfit appears in discovery results.
Directional view based on current AI response patterns, not a full product benchmark.
| Attribute | Sugarfit | Practo | Apollo Telehealth |
|---|---|---|---|
| Customer support | |||
| Doctor Supervision Required | |||
| Telemedicine Consultations Available | |||
| Pricing | |||
| Insurance Coverage Options | |||
| Licensed Provider Verification |
Immediate risk
Sugarfit is absent in 100% of buyer-intent queries while Apollo Telehealth appears in 50% of tracked prompts.
Prompts you're missingThe share of analyzed prompts where Sugarfit was not mentioned at all. Higher numbers mean more missed AI visibility.
50%
Buyer query lossesThe share of buyer-intent prompts where Sugarfit did not appear in the AI answer. Higher numbers mean more likely lost demand.
100%
Comparison coverageThe share of direct comparison prompts that explicitly include Sugarfit where Sugarfit was mentioned. Higher numbers mean stronger visibility when buyers compare options.
100%
Top competitor by mentionsThe competitor that appeared most often across all analyzed prompts, based on AI mentions in this report sample.
Apollo Telehealth (50%)
What buyers hear first
AI assistants position Sugarfit as a metabolic health specialist with personalized GLP-1 protocols, while Practo is framed as an accessible multi-doctor platform and Apollo as hospital-grade infrastructure provider with comprehensive monitoring.
What you lose if this continues
Sugarfit achieves 50% visibility parity with Apollo Telehealth in comparison queries but remains absent from 6 of 6 buyer discovery queries, indicating strong positioning only when directly compared rather than organically recommended.
What buyers hear first
None of the three brands are associated with critical buyer decision attributes like pricing transparency, insurance coverage, customer support, or licensed provider verification in AI responses, representing a category-wide attribution gap.
Act now
Develop structured citation partnerships with medical authority sources (endocrinology associations, diabetes management guidelines) to appear in generic GLP-1 discovery queries alongside Apollo Hospitals and Fortis Healthcare, not just in direct comparisons.
Every missed buyer-intent prompt is a competitor recommendation opportunity.
Everyday you may be losing hundreds of buyers using AI search. You should act now and stop losing customers to your competitors. Schedule a free call with us to learn how to win in AI search.
Related analyses
AI tools
Move from brand visibility into the AI tools buyers and operators may evaluate in this market.
Explore AI tools for this industryNeed help fixing this?
We'll show where AI is missing Sugarfit, which buyer queries matter most, and what to publish first to improve visibility.